IFNA1 and neoplasm: IFN-α, -β, and -γ are able to directly upregulate the expression of surface tumor-associated antigens (75, 76) via augmentation of MHC I class and MHC II class molecules (77), thus increasing the immunogenicity of tumor cells and making them more vulnerable to identification and subsequent destruction by the immune system.